Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 1
1956 2
1957 1
1959 3
1962 1
1967 1
1968 1
1970 7
1971 1
1975 1
1976 3
1977 1
1978 1
1979 1
1981 2
1982 2
1983 2
1985 2
1986 2
1987 1
1991 1
1992 1
1993 1
1995 2
1996 3
1997 1
1998 5
1999 5
2000 6
2001 1
2002 6
2003 5
2004 6
2005 3
2006 2
2007 5
2008 8
2009 10
2010 15
2011 18
2012 18
2013 10
2014 23
2015 47
2016 36
2017 48
2018 72
2019 83
2020 126
2021 168
2022 191
2023 250
2024 139

Text availability

Article attribute

Article type

Publication date

Search Results

1,219 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant therapy in non-small cell lung cancer.
Grant C, Hagopian G, Nagasaka M. Grant C, et al. Crit Rev Oncol Hematol. 2023 Oct;190:104080. doi: 10.1016/j.critrevonc.2023.104080. Epub 2023 Aug 1. Crit Rev Oncol Hematol. 2023. PMID: 37532102 Free article. Review.
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.
Judd J, Abdel Karim N, Khan H, Naqash AR, Baca Y, Xiu J, VanderWalde AM, Mamdani H, Raez LE, Nagasaka M, Pai SG, Socinski MA, Nieva JJ, Kim C, Wozniak AJ, Ikpeazu C, de Lima Lopes G Jr, Spira AI, Korn WM, Kim ES, Liu SV, Borghaei H. Judd J, et al. Mol Cancer Ther. 2021 Dec;20(12):2577-2584. doi: 10.1158/1535-7163.MCT-21-0201. Epub 2021 Sep 13. Mol Cancer Ther. 2021. PMID: 34518295 Free PMC article.
We sought to characterize genomic landscapes of advanced, KRAS-mutated non-small cell lung cancer (NSCLC) in a large national cohort to help guide future therapeutic development.Molecular profiles of 17,095 NSCLC specimens were obtained using DNA next-generation sequencing of 592 …
We sought to characterize genomic landscapes of advanced, KRAS-mutated non-small cell lung cancer (NSCLC) in a large national cohort to help …
Last Hug.
Nabhan C. Nabhan C. J Clin Oncol. 2021 Sep 20;39(27):3083-3084. doi: 10.1200/JCO.21.00733. Epub 2021 Jun 10. J Clin Oncol. 2021. PMID: 34110926 Free PMC article. No abstract available.
HER2 expression status in diverse cancers: review of results from 37,992 patients.
Yan M, Schwaederle M, Arguello D, Millis SZ, Gatalica Z, Kurzrock R. Yan M, et al. Cancer Metastasis Rev. 2015 Mar;34(1):157-64. doi: 10.1007/s10555-015-9552-6. Cancer Metastasis Rev. 2015. PMID: 25712293 Free PMC article.
All tissues were analyzed in a Clinical Laboratory Improvement Amendments (CLIA) laboratory (Caris Life Sciences) at the request of referring physicians. HER2 protein overexpression was found in 2.7 % of samples. ...
All tissues were analyzed in a Clinical Laboratory Improvement Amendments (CLIA) laboratory (Caris Life Sciences) at the request of r …
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
Philip PA, Azar I, Xiu J, Hall MJ, Hendifar AE, Lou E, Hwang JJ, Gong J, Feldman R, Ellis M, Stafford P, Spetzler D, Khushman MM, Sohal D, Lockhart AC, Weinberg BA, El-Deiry WS, Marshall J, Shields AF, Korn WM. Philip PA, et al. Clin Cancer Res. 2022 Jun 13;28(12):2704-2714. doi: 10.1158/1078-0432.CCR-21-3581. Clin Cancer Res. 2022. PMID: 35302596 Free PMC article.
1,219 results